Project Details
Short title | A Phase 1b Study of Eltromobopag and Azacitidine in Patients with High Risk Myelodysplastic Syndromes and Related Disorders (ELAstic) |
---|---|
Status | Finished |
Effective start/end date | 1/10/14 → 30/09/21 |
Funding
- Glaxosmithkline
- CELGENE INTERNATIONAL SARL